BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 59,000 shares, a growth of 52.8% from the May 15th total of 38,600 shares. Based on an average daily volume of 15,400 shares, the days-to-cover ratio is presently 3.8 days.
BetterLife Pharma Stock Performance
Shares of BETRF stock remained flat at $0.09 during trading hours on Friday. 4,850 shares of the stock traded hands, compared to its average volume of 18,536. The stock has a 50-day simple moving average of $0.08 and a 200 day simple moving average of $0.07. The stock has a market cap of $10.40 million, a PE ratio of -2.97 and a beta of 1.26. BetterLife Pharma has a fifty-two week low of $0.03 and a fifty-two week high of $0.10.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last released its quarterly earnings data on Wednesday, May 29th. The company reported ($0.01) EPS for the quarter.
About BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
See Also
- Five stocks we like better than BetterLife Pharma
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- MarketBeat Week in Review – 6/10 – 6/14
- What Are Dividend Champions? How to Invest in the Champions
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- Pros And Cons Of Monthly Dividend Stocks
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
